Seeking Alpha

heth247

heth247
Send Message
View as an RSS Feed
View heth247's Comments BY TICKER:
Latest  |  Highest rated
  • GCVRZ Forum [View instapost]
    Or put it in a simple way, we will need about ~3000 patients in US to switch to Lemtrada for the calendar year of 2015 to reach the $2 milestone.

    US-Emma, how likely do you think it will be?
    Feb 10, 2015. 11:38 AM | Likes Like |Link to Comment
  • GCVRZ Forum [View instapost]
    Hi, US-Emma,

    Thanks for your insightful comments.

    In your earlier posts, you mentioned, "Many patients are being infused around the world now but here in the states insurance hurdles r/t the FDA 3 failed therapies rule is holding many qualified candidate back."

    But in your recent post, you wrote "Part of the delay here is protocol establishment along with 3rd part reimbursement. Once these two resolve the cases will pour in. Most of us- MS pts- meet the third line requirement. That is not a hurdle at all."

    I found somehow difficult to put these two comments together. Can you give some numbers regarding, e.g. how much percentage of current US patients, would you estimate to meet the third line requirement?

    Many thanks!
    Feb 9, 2015. 01:36 PM | 1 Like Like |Link to Comment
  • GCVRZ Forum [View instapost]
    Agree. But I am surprised that 9M shares traded and we are only down 3 cents.
    Feb 5, 2015. 10:29 PM | Likes Like |Link to Comment
  • GCVRZ Forum [View instapost]
    Where did you get this information?
    Feb 5, 2015. 05:02 PM | Likes Like |Link to Comment
  • GCVRZ Forum [View instapost]
    Where can I confirm that the launching date is US is 2015 1Q? Thanks.
    Feb 5, 2015. 02:44 PM | Likes Like |Link to Comment
  • GCVRZ Forum [View instapost]
    I think you mean to say "fortunate", right?
    Feb 5, 2015. 01:15 PM | Likes Like |Link to Comment
  • GCVRZ Forum [View instapost]
    So in US, we got USD 2.28MM for essentially one month of sale (without insurance coverage)? That's not bad!
    Feb 5, 2015. 12:09 PM | Likes Like |Link to Comment
  • GCVRZ Forum [View instapost]
    Interviews with a MS patient and Dr. Barry Singer about Lemtrada

    http://goo.gl/eML2iJ
    Feb 4, 2015. 02:29 PM | 1 Like Like |Link to Comment
  • GCVRZ Forum [View instapost]
    It will, only if it is officially launched in 2015.
    Jan 23, 2015. 01:20 PM | Likes Like |Link to Comment
  • GCVRZ Forum [View instapost]
    s19104, is your clinic done for REMS training for lemtrada? How long is that training supposed to take to complete?

    Regarding the "opinion of most in the US erring on the side of caution and continuing treatment longer is appropriate.", what about the opinion of "time is brain", is that something still not accepted by majority of MS doctors?

    thanks
    Dec 30, 2014. 01:16 PM | 1 Like Like |Link to Comment
  • GCVRZ Forum [View instapost]
    Hi, Ruerd,

    As long as France can still launch by end of 2015 (so that to be counted towards the first milestone), I think it might turned out be a good thing. Based on my reading of tweeter and forums, I think lots of patients like Lemtrada but don't want to be among the first to try it. They want to wait until more people try it. In other words, the longer the ramp up the better.

    Maybe I don't understand it clearly, this "disapproval" is related to the insurance companies, not by European FDA, right?

    Now looking back, maybe Germany was the fastest to launch not because they are efficient, but because they were clear upfront that the government insurance won't cover it whatsoever.
    Dec 16, 2014. 02:17 PM | Likes Like |Link to Comment
  • GCVRZ Forum [View instapost]
    Per google translate:

    "But in France, its actual benefit (SMR) was deemed insufficient. Result: the health insurance does not reimburse. The laboratory that developed (still Genzyme) has preferred postpone its launch and start over from scratch. "

    So Sanofi cannot even get it pass in its own country?
    Dec 15, 2014. 01:35 PM | Likes Like |Link to Comment
  • Best Idea For 2014: Sanofi Rights Post-FDA Approval [View article]
    Based on my understanding, those people who have been on Tysabri for more than 4 years will need to get off it or switch, because the risk of PML increases significantly. It has been 7 years from 2007 when Tysabri was re-launched. Doesn't that imply a pretty large pool of candidate patients for switching?
    Dec 14, 2014. 10:53 PM | Likes Like |Link to Comment
  • Best Idea For 2014: Sanofi Rights Post-FDA Approval [View article]
    Yes, but it should be noted that Tysabri was suspended in Feb 2005 and re-approved by FDA in June 2006.
    Dec 11, 2014. 12:34 PM | Likes Like |Link to Comment
  • Photos: Empty Shelves At Sears And Kmart As Vendors Get Squeezed [View article]
    They have closed 129 store year to date and plans to close 235 store for the full year. Where do you think the remaining 106 stores come from? If a store is going to be closed within a month, isn't the emptier the better?
    Dec 4, 2014. 12:09 PM | 1 Like Like |Link to Comment
COMMENTS STATS
80 Comments
52 Likes